Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy

ClinicalTrials.gov ID: NCT00120120

Public ClinicalTrials.gov record NCT00120120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 3:16 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this multicenter, double-blind, placebo-controlled study is to evaluate the efficacy and safety of lenalidomide in the treatment of painful lumbar radiculopathy.

Study identification

NCT ID
NCT00120120
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Celgene Corporation
Industry
Enrollment
181 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2005 (Type not available)
Primary completion
Oct 2007 (Actual)
Completion
Nov 2007 (Actual)
Last update posted
Sep 23, 2009

2005 – 2007

United States locations

U.S. sites
23
U.S. states
17
U.S. cities
23
Facility City State ZIP Site status
Arizona Research Center Phoenix Arizona 85023 —
Genova Clinical Research, Inc Tucson Arizona 85741 —
Loma Linda Institution Loma Linda California 92354 —
Space Coast Neurology Palm Bay Florida 32905 —
Gold Coast Research, LLC Weston Florida 33331 —
Emory University Hospital Atlanta Georgia 30322 —
Rehab Institute of Chicago Chicago Illinois 60611 —
University of Iowa Iowa City Iowa 52242 —
Johns Hopkins Pain Center Baltimore Maryland 21205 —
Mayo Clinic Rochester Minnesota 55905 —
Washington University Pain Mgmt Ctr St Louis Missouri 63141 —
North Shore University Hospital Bethpage New York 11554 —
University of Rochester Medical CenterPain Services Rochester New York 14642 —
Duke University Medical Center Durham North Carolina 27705 —
Carolinas Pain Institute, P.A. & the Center for Clinical Research, LLC Winston-Salem North Carolina 27103 —
Research Institute of Greater Dayton Dayton Ohio 45432 —
Attn: Maryjane CerroneLehigh Valley Hospital Allentown Pennsylvania 18103-6208 —
Drexel University College of MedicineDepartment of Neurology Rm 7102 Philadelphia Pennsylvania 19102 —
Texas Tech Medical Center Department of Anesthesiology Lubbock Texas 79430 —
KRK Medical Research Richardson Texas 75080 —
Fletcher Allen Healthcare for Pain Medicine South Burlington Vermont 05403 —
University of Virginia Pain Management Center Charlottesville Virginia 22903 —
Swedish Pain Services Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00120120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 23, 2009 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00120120 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →